STSA-1001

N/A

Report date: 2024/12/18 10:01:45

Base Information

Drug NameSTSA-1001
Drug Alias NameSTSA-1001STSA1001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionNerve growth factor receptors antagonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsCancer Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesStaidson(Beijing) Biopharmaceuticals Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesStaidson(Beijing) Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsCancer Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A